Skip to main content
Premium Trial:

Request an Annual Quote

Crosslinks Licenses Tibco's Software

NEW YORK (GenomeWeb News) – Dutch software services company Crosslinks has licensed Tibco Software's Spotfire analytics platform, and will distribute it across Europe, Tibco said today.

Rotterdam-based Crosslinks was founded in 2006 as a spin off from Erasmus University Medical Center.

"When Crosslinks was launched, our aim was always to provide the Spotfire enterprise analytics platform to the academic world," Ronald Nanninga, Crosslinks CEO, said in a statement.

"Under the terms of the new license agreement signed with TIBCO at the start of the year, we have started to provide licensing agreements to academic researchers in the Netherlands and the rest of Europe who are active in the field of life sciences — especially genomics and proteomics," Nanninga said.

Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.